ArticleDiagnostics (Basel, Switzerland)2023
Prognosis Prediction in COVID-19 Patients through Deep Feature Space Reasoning.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 4 citations in OpenAlex.
- Artificial-Intelligence-Driven Algorithms for Predicting Response to Corticosteroid Treatment in Patients with Post-Acute COVID-19.Diagnostics (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 3 countries.
Funding
Abstract
The COVID-19 pandemic has presented a unique challenge for physicians worldwide, as they grapple with limited data and uncertainty in diagnosing and predicting disease outcomes. In such dire circumstances, the need for innovative methods that can aid in making informed decisions with limited data is more critical than ever before. To allow prediction with limited COVID-19 data as a case study, we present a complete framework for progression and prognosis prediction in chest X-rays (CXR) through reasoning in a COVID-specific deep feature space. The proposed approach relies on a pre-trained deep learning model that has been fine-tuned specifically for COVID-19 CXRs to identify infection-sensitive features from chest radiographs. Using a neuronal attention-based mechanism, the proposed method determines dominant neural activations that lead to a feature subspace where neurons are more sensitive to COVID-related abnormalities. This process allows the input CXRs to be projected into a high-dimensional feature space where age and clinical attributes like comorbidities are associated with each CXR. The proposed method can accurately retrieve relevant cases from electronic health records (EHRs) using visual similarity, age group, and comorbidity similarities. These cases are then analyzed to gather evidence for reasoning, including diagnosis and treatment. By using a two-stage reasoning process based on the Dempster-Shafer theory of evidence, the proposed method can accurately predict the severity, progression, and prognosis of a COVID-19 patient when sufficient evidence is available. Experimental results on two large datasets show that the proposed method achieves 88% precision, 79% recall, and 83.7% F-score on the test sets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.